title: From the guest editor: Tumor site immune modulation therapy.
authors.affiliation: From the Department of Immunobiology, Yale University School of Medicine, New Haven, CT.
authors.forename: Lieping
authors.initials: L
authors.lastname: Chen
mesh_terms: D006801:Humans; D056747:Immunomodulation / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology*; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D061026:Programmed Cell Death 1 Receptor; D011948:Receptors, Antigen, T-Cell
references.citation: Immunity. 1999 Aug;11(2):141-51
references.pmid: 10485649
references.citation: Nat Med. 2002 Aug;8(8):793-800
references.pmid: 12091876
references.citation: Nat Med. 1999 Dec;5(12):1365-9
references.pmid: 10581077
references.citation: J Clin Oncol. 2010 Jul 1;28(19):3167-75
references.pmid: 20516446
references.citation: EMBO J. 1992 Nov;11(11):3887-95
references.pmid: 1396582
references.citation: J Exp Med. 2000 Oct 2;192(7):1027-34
references.pmid: 11015443